Preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for the evaluation of curability and resectability in patients with pancreatic adenocarcinoma

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 14, Issue 6, 2007, Pages 539-544

  Fujioka, Shuichi ^a,b   Misawa, Takeyuki ^a   Okamoto, Tomoyoshi ^a   Gocho, Takeshi ^a   Futagawa, Yasuro ^a   Ishida, Yuichi ^a   Yanaga, Katsuhiko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Carbohydrate antigen 19 9; Carcinoembryonic antigen; Curability; Pancreatic cancer; Resectability

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HUMAN; LIVER METASTASIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS SURGERY; PERITONEUM METASTASIS; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; TREATMENT FAILURE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; ROC CURVE; TUMOR MARKERS, BIOLOGICAL;

EID: 36749038370     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-006-1184-3     Document Type: Article

References (36)

1. SF Sener A Fremgen HR Menck DP Winchester 1999 Pancreatic cancer: A report of treatment and survival trends for 100 313 patients diagnosed from 1985-1995, using the National Cancer Database J Am Coll Surg 189 1-7 10401733 10.1016/S1072-7515(99)00075-7 1:STN:280:DyaK1MzivVWlsg%3D%3D
2. L Blaszkowsky 1998 Treatment of advanced and metastatic pancreatic cancer Front Biosci 3 214-25
3. S Egawa K Takeda S Fukuyama F Motoi M Sunamura S Matsuno 2004 Clinicopathological aspects of small pancreatic cancer Pancreas 28 235-40 15084963 10.1097/00006676-200404000-00004
4. HG Beger F Gansauge G Leder 2002 Pancreatic cancer: Who benefits from curative resection? Can J Gastroenterol 16 117-20 11875596
5. C Pasquali C Sperti C Filipponi S Pedrazzoli 2002 Epidemiology of pancreatic cancer in Northeastern Italy: Incidence, resectability rate, hospital stay, costs and survival (1990-1992) Dig Liver Dis 34 723-31 12469800 10.1016/S1590-8658(02)80024-X 1:STN:280:DC%2BD38jgslyhtQ%3D%3D
6. B Kedra T Popiela M Sierzega A Precht 2001 Prognostic factors of long-term survival after resective procedures for pancreatic cancer Hepatogastroenterology 48 1762-6 11813619 1:STN:280:DC%2BD38%2Fos1egtw%3D%3D
7. G Benassai M Mastrorilli G Quarto A Cappiello U Giani P Forestieri F Mazzeo 2000 Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas J Surg Oncol 73 212-8 10797334 10.1002/ (SICI)1096-9098(200004)73:4<212::AID-JSO5>3.0.CO;2-D 1:STN:280:DC%2BD3c3lvF2hsg%3D%3D
8. JP Neoptolemos DD Stocken JA Dunn J Almond HG Beger P Pederzoli 2001 Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial Ann Surg 234 758-68 11729382 10.1097/ 00000658-200112000-00007 1:STN:280:DC%2BD38%2FlvFSqsg%3D%3D
9. A Okamoto K Tsuruta K Karasawa N Miyanari G Matsumoto T Kamisawa N Egawa 2003 Resection versus palliation: Treatment of stage III and IVA carcinomas of the pancreas employing intraoperative radiation World J Surg 27 599-605 12715231 10.1007/s00268-003-6579-6
10. J Baulieux JR Delpero 2000 Surgical treatment of pancreatic cancer: curative resections Ann Chir 125 609-17 11051689 10.1016/ S0003-3944(00)00251-0 1:STN:280:DC%2BD3crgsVWksQ%3D%3D
11. S Pedrazzoli C Sperti C Pasquali 1994 Prediction of resectability and of surgical risk in pancreatic carcinoma; conditioning factors of survival after resective intervention Chir Ital 46 30-8 7954982 1:STN:280:ByqD2c3psVM%3D
12. P Piantino A Andriulli T Gindro F Pecchio G Masoero G Cavallini 1996 CA 19-9 assay in differential diagnosis of pancreatic carcinoma from inflammatory pancreatic diseases Am J. Gastroenterol 81 436-9
13. F Safi W Schlosser G Kolb HG Beger 1997 Diagnostic value of CA 19-9 in patients with pancreatic cancer and nonspecific gastrointestinal symptoms J Gastrointest Surg 1 106-12 9834336 10.1016/ S1091-255X(97)80097-2 1:STN:280:DC%2BD28nhslSguw%3D%3D
14. MG Schlieman HS Ho RJ Bold 2003 Utility of tumor markers in determining resectability of pancreatic cancer Arch. Surg 138 951-5 12963650 10.1001/ archsurg.138.9.951
15. G Cappelli S Paladini A D'Agata 1999 Tumor markers in the diagnosis of pancreatic cancer Tumori 85 1 Suppl 1 S19-S21 10235075 1:STN:280:DyaK1M3ltFersQ%3D%3D
16. G Civardi L Cerri L Cavanna F Fornari M Di Stasi F Binelli 1986 Diagnostic accuracy of a new tumor serologic marker, CA 19-9: Comparison with CEA Tumori 72 621-4 3468674 1:STN:280:BiiC387lvFQ%3D
17. G Del Favero C Fabris M Plebani A Panucci A Piccoli L Perobelli 1986 CA 19-9 and carcinoembryonic antigen in pancreatic cancer diagnosis Cancer 15 57 1576-9 10.1002/ 1097-0142(19860415)57:8<1576::AID-CNCR2820570823>3.0.CO;2-9
18. T Frebourg E Bercoff N Manchon J Senant JP Basuyau P Breton 1988 The evaluation of CA 19-9 antigen level in the early detection of pancreatic cancer. A prospective study of 866 patients Caner 62 2287-90 10.1002/ 1097-0142(19881201)62:11<2287::AID-CNCR2820621103>3.0.CO;2-H 1:STN:280:BiaD38fhtFE%3D
19. J Lundin PJ Roberts P Kuusela C Haglund 1994 The prognostic value of preoperative serum levels of CA 19-9 and CEA in patients with pancreatic cancer Br J Cancer 69 515-9 7510116 1:STN:280:ByuC28fpsF0%3D
20. F Safi W Schlosser S Falkenreck HGC Beger 1996 A 19-9 serum course and prognosis of pancreatic cancer Int. J. Pancreatol 20 155-61 9013275 1:STN:280:ByiC28rltFA%3D
21. LH Sobin Ch Wittekind 2003 UICC TNM classification of malignant tumors 6th ed Wiley Liss New York 3
22. C Catalano A Laghi F Fraioli F Pediconi A Napoli M Danti 2003 Pancreatic carcinoma: The role of high-resolution multislice spiral CT in the diagnosis and assessment of resectability Eur Radiol 13 149-56 12541123 10.1007/s00330-003-0008-y
23. SJ Diehl KJ Lehmann M Sadick R Lachmann M Georgi 1998 Pancreatic cancer: value of dual-phase helical CT in assessing resectability Radiology 206 373-8 9457188 1:STN:280:DyaK1c7hvVeqsA%3D%3D
24. J Durup Scheel-Hincke MB Mortensen N Qvist CP Hovendal 1999 TNM staging and assessment of resectability of pancreatic cancer by laparoscopic ultrasonography Surg. Endosc 13 967-71 10526028 10.1007/s004649901148 1:STN:280:DyaK1MvlslGitg%3D%3D
25. EH Tilleman OR Busch WA Bemelman TM van Gulik H Obertop DJ Gouma 2004 Diagnostic laparoscopy in staging pancreatic carcinoma: Developments during the past decade J. Hepatobiliary. Pancreat. Surg 11 11-6 15747029 10.1007/s00534-002-0784-9
26. D Delbeke CW Pinson 2004 Pancreatic tumors: Role of imaging in the diagnosis, staging, and treatment J. Hepatobiliary. Pancreat. Surg 11 4-10 15747028 10.1007/s00534-002-0775-x
27. KC Conlon DS Klimstra MF Brennan 1996 Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors Ann Surg 223 273-9 8604907 10.1097/ 00000658-199603000-00007 1:STN:280:BymC1Mbgtlc%3D
28. MG Schlieman HS Ho RJ Bold 2003 Utility of tumor markers in determining resectability of pancreatic cancer Arch. Surg 138 951-5 12963650 10.1001/ archsurg.138.9.951
29. EM Loyer CL David RA Dubrow DB Evans C Charnsangavej 1996 Vascular involvement in pancreatic adenocarcinoma: Reassessment by thin-section CT Abdom. Imaging 21 202-6 8661548 10.1007/s002619900046 1:STN:280:BymB28bnsFQ%3D
30. GM Fuhrman C Charnsangavej JL Abbruzzese KR Cleary RG Martin CJ Fenoglio DB Evans 1994 Thin-section contrast-enhanced computed tomography accurately predicts the resectability of malignant pancreatic neoplasms Am. J. Surg 167 104-11 7906097 10.1016/0002-9610(94)90060-4 1:STN:280:ByuC2cvmvFY%3D
31. MA Tempero E Uchida H Takasaki DA Burnett Z Steplewski PM Pour 1987 Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer Cancer Res 47 5501-3 3308077 1:STN:280:BieD3c3gtlM%3D
32. M Brockhaus JL Magnani M Blaszczyk Z Steplewski H Koprowski KA Karlsson 1981 Monoclonal antibodies directed against the human Leb blood group antigen J. Biol. Chem 256 13 223-5
33. LM Tibbetts CM Doremus GN Tzanakakis MP Vezeridis 1993 Liver metastases with ten human colon carcinoma cell lines in nude mice and association with carcinoembryonic antigen production Cancer 71 315-21 8422623 10.1002/1097-0142(19930115)71:2<315::AID-CNCR2820710208>3.0.CO;2-B 1:STN:280:ByyC3sjhslc%3D
34. EA Bakalakos WE Burak Jr DC Young EW Martin Jr 1999 Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases? Am J Surg 177 2-6 10037299 10.1016/ S0002-9610(98)00303-1 1:STN:280:DyaK1M7lsV2jsQ%3D%3D
35. G Steele Jr R Bleday RJ Mayer A Lindblad N Petrelli D Weaver 1991 A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Goup Protocol 6584 J Clin Oncol 9 1105-12 2045852
36. EA Alsabti MH Saffo 1979 Plasma levels of CEA as a prognostic marker in carcinoma of urinary bladder Urol Int 34 387-92 494440 1:STN:280:Bi%2BD3sjkvFY%3D